Specific and potent interactions of carbamazepine with brain adenosine receptors.

[1]  D. Rubinow,et al.  Biochemical effects of carbamazepine: Relationship to its mechanisms of action in affective illness , 1983, Progress in Neuro-psychopharmacology and Biological Psychiatry.

[2]  R. Post,et al.  Kindling and Carbamazepine in Affective Illness , 1982, The Journal of nervous and mental disease.

[3]  W. Catterall,et al.  Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine. , 1982, Molecular pharmacology.

[4]  J. Patel,et al.  Specific calcium antagonist binding sites in brain. , 1982, Life sciences.

[5]  L. P. Davies,et al.  A purinergic component in the anticonvulsant action of carbamazepine? , 1982, European journal of pharmacology.

[6]  J. Boulenger,et al.  Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864. , 1982, Molecular pharmacology.

[7]  J. Patel,et al.  [3H]Nitrobenzylthioinosine Binding as a Probe for the Study of Adenosine Uptake Sites in Brain , 1982, Journal of neurochemistry.

[8]  R. Post,et al.  Carbamazepine, Temporal Lobe Epilepsy, and Manic-Depressive Illness , 1982 .

[9]  F. Goodwin,et al.  Characterization of adenosine receptors in brain using N6 cyclohexyl [3H]adenosine , 1982, Brain Research.

[10]  J. Patel,et al.  Properties of [3H] beta-carboline-3-carboxylate ethyl ester binding to the benzodiazepine receptor. , 1981, Life sciences.

[11]  P. Marangos,et al.  Studies on the relationship of gamma-aminobutyric acid-stimulated diazepam binding and the gamma-aminobutyric acid receptor. , 1981, Molecular pharmacology.

[12]  S. Snyder,et al.  Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Post,et al.  Carbamazepine in manic-depressive illness: a new treatment. , 1980, The American journal of psychiatry.

[14]  F. Goodwin,et al.  Demonstration of specific high affinity binding sites for [3H] imipramine in human brain. , 1980, Life sciences.

[15]  J. Leysen,et al.  Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. , 1978, Biochemical pharmacology.

[16]  R. Julien,et al.  Effect of Carbamazepine on the In Vitro Uptake and Release of Norepinephrine in Adrenergic Nerves of Rabbit Aorta and in Whole Brain Synaptosomes , 1977, Epilepsia.

[17]  E. Lewin,et al.  Cyclic AMP Accumulation in Cerebral Cortical Slices: Effect of Carbamazepine, Phenobarbital, and Phenytoin , 1977, Epilepsia.

[18]  S. Snyder,et al.  Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. , 1977, Molecular pharmacology.

[19]  S. Snyder,et al.  Beta adrenergic receptor binding in membrane preparations from mammalian brain. , 1976, Molecular pharmacology.

[20]  J. Wada,et al.  Prophylactic effects of phenytoin, phenobarbital, and carbamazepine examined in kindling cat preparations. , 1976, Archives of neurology.

[21]  B. G. White,et al.  Carbamazepine for epilepsy , 1974, Neurology.

[22]  S. Snyder,et al.  Muscarinic cholinergic binding in rat brain. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Garattini,et al.  Carbamazepine plasma and tissue levels in the rat. , 1971, Biochemical pharmacology.

[24]  R. Post,et al.  The efficacy of carbamazepine in affective illness. , 1984, Advances in biochemical psychopharmacology.

[25]  Maynert Ew,et al.  The role of the neurotransmitters in the epilepsies. , 1975 .